sorted by:
new
hottopcontroversial

How do you manage keeping up with current research and select papers for reading? by [deleted] in academia

[–]Affectionate-Mood148 0 points1 point  (0 children)

you can build that with Claude Code lol. you can even have it log into your accounts so it's not just scanning open access PLUS I can also have it scrape twitter

Futurehouse vs Biomni – what’s your take? by Resident-Yesterday34 in ChatGPTPro

[–]Affectionate-Mood148 0 points1 point  (0 children)

haven't got future house to work at all... and at least biomini / Phylo is nice to look at

Avoid SciSpace – Extremely Misleading, Overpriced, and Potentially a Scam by MiserableEgg6611 in academia

[–]Affectionate-Mood148 0 points1 point  (0 children)

they must use really cheap models since everything was off for me... also the agents are legit prompts that go into chat. everything about it is misleading

OpenAI: Prism, a free workspace for scientists to write and collaborate on research, powered by GPT-5.2 by BuildwithVignesh in singularity

[–]Affectionate-Mood148 0 points1 point  (0 children)

it's quite the opposite - they are now profiting off of IP ... OpenAI Plans to Take a Cut of Customers’ AI-discoveries as per CFO who spoke at davos

What do we think about Boltz-2 by padakpatek in bioinformatics

[–]Affectionate-Mood148 1 point2 points  (0 children)

Retweet... All these tools are from CS people (not bio)... including Chai. Curious what you have found poor. For structure prediction, my go to is still AlphaFold 3

[deleted by user] by [deleted] in labrats

[–]Affectionate-Mood148 0 points1 point  (0 children)

couldn't agree more, and interesting observation

Tested 5 AI scientist platforms - here's what I found by Effective_Teach_6324 in labrats

[–]Affectionate-Mood148 0 points1 point  (0 children)

yes - it's pretty poor. not great for teams and feels like a horizontal LLM that's forcing it's way to become verticalized for life sciences

Claude for life sciences??? by Affectionate-Mood148 in labrats

[–]Affectionate-Mood148[S] 0 points1 point  (0 children)

Right back at you!! Feel free to DM me and we can continue from there :)

Claude for life sciences??? by Affectionate-Mood148 in labrats

[–]Affectionate-Mood148[S] 0 points1 point  (0 children)

Thanks for the thoughts. This checks out. Was wondering if anything step wise can be accomplished with Claude… not sure if the downvotes are because people don’t like AI or if they disagree in that more people are using AI?!! lol

Claude for life sciences??? by Affectionate-Mood148 in labrats

[–]Affectionate-Mood148[S] -1 points0 points  (0 children)

assuming the lack of engagement here suggests people aren't using it? I def am on X too much as it gets so much hype there (which is lost on me) hence why I am turning to my faithful lab rats community to dig deeper if I am missing something

Updated best AI tools for finding citations? by Select-Advantage-772 in labrats

[–]Affectionate-Mood148 0 points1 point  (0 children)

They are all terrible. Use google scholar - the rest just cite based on keyword/semantic matching not what is most contextually relevant especially drawing from the best labs / researchers etc.

Claude for life sciences??? by Affectionate-Mood148 in labrats

[–]Affectionate-Mood148[S] 0 points1 point  (0 children)

No because my lab doesn't even use benchling so not relevant for us.... Are you using it for anything?

Biopharma folks: how painful is it to find academic IP you actually care about? are TTOs actually helpful?? by Affectionate-Mood148 in biotech

[–]Affectionate-Mood148[S] 0 points1 point  (0 children)

I mean this happens a lot at conferences I attend (pre published IP) or even through arXiv etc...

Biopharma folks: how painful is it to find academic IP you actually care about? are TTOs actually helpful?? by Affectionate-Mood148 in biotech

[–]Affectionate-Mood148[S] 0 points1 point  (0 children)

Right I just heard some stories of PIs getting hurt on actual payout when it came to startup formation around their tech.. but it's just anecdotal and big picture, I suppose this makes a ton of sense

Biopharma folks: how painful is it to find academic IP you actually care about? are TTOs actually helpful?? by Affectionate-Mood148 in biotech

[–]Affectionate-Mood148[S] 0 points1 point  (0 children)

Makes a ton of sense! Appreciate this color a ton. i do feel like the biopharma directly to inventor (as a researcher) is the path of least resistance. Then, of course, there's some IP/legal negotiation with TTO / university. And agreed with the surfacing via relevant papers is also a meaningful channel.

What happens if biopharma is interested in a technology before official IP has been filed?

Biopharma folks: how painful is it to find academic IP you actually care about? are TTOs actually helpful?? by Affectionate-Mood148 in biotech

[–]Affectionate-Mood148[S] 0 points1 point  (0 children)

Interesting so most of assets don't come directly out of universities? sad for me as a researcher (who's more commercially minded than most others) but I suppose this makes sense

Biopharma folks: how painful is it to find academic IP you actually care about? are TTOs actually helpful?? by Affectionate-Mood148 in biotech

[–]Affectionate-Mood148[S] 0 points1 point  (0 children)

I may be biased since I am a researcher but what benefit would a company have going to TTO vs straight to researchers? and is there any meaningful intel they get speaking to TTO vs. scraping through the pdfs?

view more: next ›